Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher ...

A comprehensive new study supports evidence of the myriad health benefits of GLP-1 medications like Ozempic and Mounjaro — ...

A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...

CMS has selected 15 new drugs for the next round of Medicare ... health among a diverse multiethnic cohort of Asian adults with type 2 diabetes, researchers found in a retrospective cohort study.

Insulin, sulfonylureas, and TZDs are diabetes medications that may cause weight gain. But some, like metformin, may have weight loss potential. Others may be neutral to any weight changes.

By Dr. Priyom Bose, Ph.D. Factors such as sex, type of insurance plan, and the use of common medications influenced whether ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Researchers from the University of California, Irvine, were the first to report an improvement in severe diabetes-related ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Type 2 diabetes is a condition where the body doesn’t make enough of the hormone insulin or use it effectively. Here, MDs ...